Immunosignature Technology Platforms News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Press release content from Business Wire. The AP news staff was not involved in its creation.
Calviri Appoints Marc Wolff Chief Executive Officer
April 12, 2021 GMT
Calviri Appoints Marc Wolff Chief Executive Office (Photo: Business Wire).
PHOENIX (BUSINESS WIRE) Apr 12, 2021
Calviri announces the appointment of Marc Wolff as Chief Executive Officer. Founder and current CEO, Stephen Albert Johnston, will continue to serve as Chairman of the Board of Directors and Founding CEO.
ADVERTISEMENT
Calviri Appoints Marc Wolff Chief Executive Office (Photo: Business Wire).
“We are thrilled to welcome Marc Wolff to Calviri as we progress to commercialization. Marc’s successful life science and healthcare management experience, in both public and private corporations, makes him an excellent individual to lead the company toward significant growth objectives,” said Johnston, Founding CEO. “We were impressed as we watched his accomplishments at Aldevron ....

United States , Marc Wolff , Stephen Albert Johnston , Cynthia Hibbard , Office Photo , Arizona State University , Cardinal Health , Biodesign Institute , Immunosignature Technology Platforms , Calviri Inc , Chief Executive , Appoints Marc Wolff Chief Executive Office , Business Wire , Frameshift Peptide , Wexford Science , Chief Operating Officer , Chief Financial Officer , Executive Changes , Pharmaceutical Manufacturing , Health Care Industry , Corporate News , Production Facilities , Corporate Management , North America , ஒன்றுபட்டது மாநிலங்களில் , மார்க் ஓநாய் ,